HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viscolin reduces VCAM-1 expression in TNF-α-treated endothelial cells via the JNK/NF-κB and ROS pathway.

Abstract
Viscolin, a major active component in a chloroform extract of Viscum coloratum, has antioxidative and anti-inflammatory properties. We focused on its effects on the expression of vascular cell adhesion molecule-1 (VCAM-1) in tumor necrosis factor-α (TNF-α)-treated human umbilical vein endothelial cells (HUVECs). The TNF-α-induced expression of VCAM-1 was significantly reduced by respectively 38±7 or 34±16% when HUVECs were pretreated with 10 or 30μM viscolin, as shown by Western blotting, and was also significantly reduced by pretreatment with the antioxidants N-acetylcysteine, diphenylene iodonium chloride, and apocynin. Viscolin also reduced TNF-α-induced VCAM-1 mRNA expression and promoter activity, decreased reactive oxygen species (ROS) production, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and significantly reduced the binding of monocytes to TNF-α-stimulated HUVECs. The attenuation of TNF-α-induced VCAM-1 expression and cell adhesion was partly mediated by a decrease in JNK phosphorylation. Furthermore, viscolin reduced VCAM-1 expression in the aorta of TNF-α-treated mice in vivo. Taken together, these data show that viscolin inhibits TNF-α-induced JNK phosphorylation, nuclear translocation of NF-κB p65, and ROS generation and thereby suppresses VCAM-1 expression, resulting in reduced adhesion of leukocytes. These results also suggest that viscolin may prevent the development of atherosclerosis and inflammatory responses.
AuthorsChan-Jung Liang, Shu-Huei Wang, Yung-Hsiang Chen, Shih-Sheng Chang, Tong-Long Hwang, Yann-Lii Leu, Ying-Chih Tseng, Chi-Yuan Li, Yuh-Lien Chen
JournalFree radical biology & medicine (Free Radic Biol Med) Vol. 51 Issue 7 Pg. 1337-46 (Oct 01 2011) ISSN: 1873-4596 [Electronic] United States
PMID21767632 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Biphenyl Compounds
  • RNA, Messenger
  • Reactive Oxygen Species
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • viscolin
  • NADPH Oxidases
  • MAP Kinase Kinase 4
  • Propane
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Aorta (cytology, drug effects, metabolism)
  • Atherosclerosis (prevention & control)
  • Biphenyl Compounds (pharmacology)
  • Blotting, Western
  • Cell Adhesion (drug effects)
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Endothelial Cells (cytology, drug effects, metabolism)
  • Endothelium, Vascular (cytology, drug effects, metabolism)
  • Human Umbilical Vein Endothelial Cells (drug effects, metabolism)
  • Humans
  • MAP Kinase Kinase 4 (antagonists & inhibitors, genetics, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Monocytes (drug effects)
  • NADPH Oxidases (antagonists & inhibitors, genetics, metabolism)
  • Phosphorylation (drug effects)
  • Propane (analogs & derivatives, pharmacology)
  • RNA, Messenger (analysis)
  • Reactive Oxygen Species (antagonists & inhibitors, metabolism)
  • Transcription Factor RelA (antagonists & inhibitors, genetics, metabolism)
  • Tumor Necrosis Factor-alpha (adverse effects, pharmacology)
  • Vascular Cell Adhesion Molecule-1 (biosynthesis)
  • Viscum (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: